Are the cardiovascular effects and ‘5-HT syndrome’ induced by MDL 73,975 and flesinoxan in the dog mediated by 5-HT1A receptors?

This publication has 31 references indexed in Scilit:

• Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat
  European Journal of Pharmacology, 1990
• Is Blockade of α1-Adrenoceptors Favourable in Hypotension Induced by Stimulation of Serotonin1A Receptors in Conscious Dogs?
  Drugs, 1990
• NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)
  European Journal of Pharmacology, 1988
• Central 5-HT1A Receptors and the Mechanism of the Central Hypotensive Effect of (+)8-OH-DPAT, DP-5-CT, R28935, and Urapidil
  Journal of Cardiovascular Pharmacology, 1988
• Antihypertensive effects of 8-hydroxy-2-(di-n-propylanmino)tetralin (8-OH-DPAT) in conscious dogs
  European Journal of Pharmacology, 1988
• Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission
  Trends in Pharmacological Sciences, 1987
• Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis
  Journal of Cardiovascular Pharmacology, 1987
• Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists
  British Journal of Pharmacology, 1986
• 8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist
  Journal of Medicinal Chemistry, 1981
• Diminished Baroreflex Sensitivity in High Blood Pressure
  Circulation, 1969